Cargando…

Lewy body disease or diseases with Lewy bodies?

The current nosological concept of α-synucleinopathies characterized by the presence of Lewy bodies (LBs) includes Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), and dementia with Lewy bodies (DLB), for which the term “Lewy body disease” (LBD) has recently been proposed due to their c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menšíková, Kateřina, Matěj, Radoslav, Colosimo, Carlo, Rosales, Raymond, Tučková, Lucie, Ehrmann, Jiří, Hraboš, Dominik, Kolaříková, Kristýna, Vodička, Radek, Vrtěl, Radek, Procházka, Martin, Nevrlý, Martin, Kaiserová, Michaela, Kurčová, Sandra, Otruba, Pavel, Kaňovský, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748648/ https://www.ncbi.nlm.nih.gov/pubmed/35013341 http://dx.doi.org/10.1038/s41531-021-00273-9

Ejemplares similares

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Whole Exome Sequencing Study in Isolated South-Eastern Moravia (Czechia) Population Indicates Heterogenous Genetic Background for Parkinsonism Development
por: Kolarikova, Kristyna, et al.
Publicado: (2022)

Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report
por: Bartonikova, Tereza, et al.
Publicado: (2016)

High-Throughput Sequencing Haplotype Analysis Indicates in LRRK2 Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic
por: Kolarikova, Kristyna, et al.
Publicado: (2022)

Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome
por: Kaiserová, Michaela, et al.
Publicado: (2021)

New endemic familial parkinsonism in south Moravia, Czech Republic and its genetical background
por: Bartoníková, Tereza, et al.
Publicado: (2018)

Deep Brain Stimulation Effects on Gait Pattern in Advanced Parkinson’s Disease Patients
por: Navratilova, Daniela, et al.
Publicado: (2020)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Jellinger, Kurt A.
Publicado: (2022)

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study
por: Kurcova, Sandra, et al.
Publicado: (2018)

Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of RHD, KEL, and RHCE from Cell-Free Fetal DNA of Maternal Plasma
por: Vodicka, Radek, et al.
Publicado: (2021)

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report
por: Mensikova, Katerina, et al.
Publicado: (2016)

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
por: Kaiserova, Michaela, et al.
Publicado: (2021)

Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia
por: Hok, Pavel, et al.
Publicado: (2021)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Lewy body constipation
por: Sakakibara, Ryuji, et al.
Publicado: (2019)

Molecular Pathology of Lewy Body Diseases
por: Beyer, Katrin, et al.
Publicado: (2009)

Parkin Disease and the Lewy Body Conundrum
por: Doherty, Karen M, et al.
Publicado: (2013)

Clinical biomarkers for Lewy body diseases
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
por: Koníčková, Dorota, et al.
Publicado: (2022)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Fabry Disease With Concomitant Lewy Body Disease
por: Del Tredici, Kelly, et al.
Publicado: (2020)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
por: Hatton, Christopher, et al.
Publicado: (2020)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Targeting BPOZ-2 in Lewy body disease
por: Roy, Avik
Publicado: (2016)

Topography of cortical thinning in the Lewy body diseases
por: Ye, Rong, et al.
Publicado: (2020)

The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies
por: Wulf, Maximilian, et al.
Publicado: (2022)

Detection of Unknown and Rare Pathogenic Variants in Antithrombin, Protein C and Protein S Deficiency Using High-Throughput Targeted Sequencing
por: Vrtel, Petr, et al.
Publicado: (2022)

Cognitive profile in prodromal dementia with Lewy bodies
por: Kemp, Jennifer, et al.
Publicado: (2017)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_srdancf4t0s5lpvd7des6q0mtr